"Antihypertensive Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
| Descriptor ID |
D000959
|
| MeSH Number(s) |
D27.505.954.411.162
|
| Concept/Terms |
Antihypertensive Agents- Antihypertensive Agents
- Agents, Antihypertensive
- Antihypertensives
- Anti-Hypertensives
- Anti Hypertensives
- Antihypertensive Drugs
- Drugs, Antihypertensive
- Anti-Hypertensive Agents
- Agents, Anti-Hypertensive
- Anti Hypertensive Agents
- Anti-Hypertensive Drugs
- Anti Hypertensive Drugs
- Drugs, Anti-Hypertensive
|
Below are MeSH descriptors whose meaning is more general than "Antihypertensive Agents".
Below are MeSH descriptors whose meaning is more specific than "Antihypertensive Agents".
This graph shows the total number of publications written about "Antihypertensive Agents" by people in this website by year, and whether "Antihypertensive Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 3 | 0 | 3 |
| 1997 | 2 | 0 | 2 |
| 1998 | 2 | 1 | 3 |
| 1999 | 5 | 0 | 5 |
| 2001 | 3 | 0 | 3 |
| 2002 | 1 | 0 | 1 |
| 2003 | 5 | 9 | 14 |
| 2004 | 1 | 4 | 5 |
| 2005 | 5 | 1 | 6 |
| 2006 | 8 | 1 | 9 |
| 2007 | 8 | 5 | 13 |
| 2008 | 12 | 6 | 18 |
| 2009 | 12 | 11 | 23 |
| 2010 | 6 | 5 | 11 |
| 2011 | 9 | 3 | 12 |
| 2012 | 7 | 3 | 10 |
| 2013 | 8 | 2 | 10 |
| 2014 | 10 | 2 | 12 |
| 2015 | 9 | 1 | 10 |
| 2016 | 6 | 6 | 12 |
| 2017 | 6 | 4 | 10 |
| 2018 | 10 | 2 | 12 |
| 2019 | 12 | 3 | 15 |
| 2020 | 8 | 5 | 13 |
| 2021 | 3 | 5 | 8 |
| 2022 | 1 | 3 | 4 |
| 2023 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antihypertensive Agents" by people in Profiles.
-
Bolin LP, Crane PB, Gunn LH. Exploring Cytokine Networks in Resistant Hypertension. Nurs Res. 2024 Jan-Feb 01; 73(1):16-25.
-
Han KD, Hwang Y, Park SH. Blood pressure status affects atrial fibrillation in diabetic end-stage renal disease. PLoS One. 2023; 18(4):e0283875.
-
Matanes F, Siddiqui M, Velasco A, Sharifov O, Kreps E, Dudenbostel T, Judd EK, Zhang B, Lloyd SG, Oparil S, Calhoun DA. Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension. J Clin Hypertens (Greenwich). 2023 05; 25(5):416-425.
-
Singer AG, LaBine L, Katz A, Yogendran M, Lix L. Primary medication nonadherence in a large primary care population: Observational study from Manitoba. Can Fam Physician. 2022 07; 68(7):520-527.
-
Jafar TH, Tan NC, Shirore RM, Allen JC, Finkelstein EA, Hwang SW, Koong AYL, Moey PKS, Kang GC, Goh CWT, Subramanian RC, Thiagarajah AG, Ramakrishnan C, Lim CW, Liu J. Integration of a multicomponent intervention for hypertension into primary healthcare services in Singapore-A cluster randomized controlled trial. PLoS Med. 2022 06; 19(6):e1004026.
-
Tseng VL, Topouzis F, Yu F, Keskini C, Pappas T, Founti P, Anastasopoulos E, Harris A, Wilson MR, Coleman AL. Association Between Dietary Salt Intake and Open Angle Glaucoma in the Thessaloniki Eye Study. J Glaucoma. 2022 07 01; 31(7):494-502.
-
Matanes F, Khan MB, Siddiqui M, Dudenbostel T, Calhoun D, Oparil S. An Update on Refractory Hypertension. Curr Hypertens Rep. 2022 07; 24(7):225-234.
-
Donneyong MM, Fischer MA, Langston MA, Joseph JJ, Juarez PD, Zhang P, Kline DM. Examining the Drivers of Racial/Ethnic Disparities in Non-Adherence to Antihypertensive Medications and Mortality Due to Heart Disease and Stroke: A County-Level Analysis. Int J Environ Res Public Health. 2021 12 02; 18(23).
-
Aryal SR, Siddiqui M, Sharifov OF, Coffin MD, Zhang B, Gaddam KK, Gupta H, Denney TS, Dell'Italia LJ, Oparil S, Calhoun DA, Lloyd SG. Spironolactone Reduces Aortic Stiffness in Patients With Resistant Hypertension Independent of Blood Pressure Change. J Am Heart Assoc. 2021 09 07; 10(17):e019434.
-
Edosuyi O, Choi M, Igbe I, Oyekan A. Fumarate exerted an antihypertensive effect and reduced kidney injury molecule (KIM)-1 expression in deoxycorticosterone acetate-salt hypertension. Clin Exp Hypertens. 2021 Aug 18; 43(6):555-564.